Javascript must be enabled to continue!
Utilization and Cost of Health Care Services for Children With Attention-Deficit/Hyperactivity Disorder
View through CrossRef
Background.Despite an increasing prevalence of diagnosed attention-deficit/hyperactivity disorder (ADHD) among children, the impact of ADHD on utilization and costs of health care services is largely unknown.Objective.To examine differences in health care utilization and costs between children with and without ADHD.Design.Retrospective matched cohort study conducted from January 1 to December 31, 1997.Setting.Health maintenance organization in western Washington State.Participants.Children aged 3 through 17 years who were continuously enrolled in the health maintenance organization and used services during 1997 were eligible. Children were identified with ADHD if they had a diagnosis of ADHD or a prescription for a stimulant medication using automated patient files. Children without ADHD were randomly selected as controls and matched 4:1 to children with ADHD on age and sex.Outcome Measure.Utilization and costs of specific categories of health care services.Results.A total of 2992 children (5.2%) were identified with ADHD. Children with ADHD incurred significantly greater per capita total costs ($1465 vs $690) than children without ADHD. Children with ADHD had 9.9 times more outpatient mental health visits (1.35/year vs 0.14/year), 3.4 times more pharmacy fills (11.25/year vs 3.30/year), and 1.6 times more primary care visits (3.84/year vs 2.36/year) than children without ADHD. The adjusted incremental costs were estimated to be $375 (95% confidence interval: $336–$416) for children with ADHD alone and $812 (95% confidence interval: $671–$973) for children with ADHD plus coexisting mental health disorders.Conclusions.Children with ADHD use significantly more health care resources and incur significantly higher costs than children without ADHD. Coexisting mental health disorders substantially increase the cost of treating ADHD. Resource allocation decisions should consider the contributions of primary care, outpatient mental health, and pharmacy costs to the overall costs of care for children with ADHD.
American Academy of Pediatrics (AAP)
Title: Utilization and Cost of Health Care Services for Children With Attention-Deficit/Hyperactivity Disorder
Description:
Background.
Despite an increasing prevalence of diagnosed attention-deficit/hyperactivity disorder (ADHD) among children, the impact of ADHD on utilization and costs of health care services is largely unknown.
Objective.
To examine differences in health care utilization and costs between children with and without ADHD.
Design.
Retrospective matched cohort study conducted from January 1 to December 31, 1997.
Setting.
Health maintenance organization in western Washington State.
Participants.
Children aged 3 through 17 years who were continuously enrolled in the health maintenance organization and used services during 1997 were eligible.
Children were identified with ADHD if they had a diagnosis of ADHD or a prescription for a stimulant medication using automated patient files.
Children without ADHD were randomly selected as controls and matched 4:1 to children with ADHD on age and sex.
Outcome Measure.
Utilization and costs of specific categories of health care services.
Results.
A total of 2992 children (5.
2%) were identified with ADHD.
Children with ADHD incurred significantly greater per capita total costs ($1465 vs $690) than children without ADHD.
Children with ADHD had 9.
9 times more outpatient mental health visits (1.
35/year vs 0.
14/year), 3.
4 times more pharmacy fills (11.
25/year vs 3.
30/year), and 1.
6 times more primary care visits (3.
84/year vs 2.
36/year) than children without ADHD.
The adjusted incremental costs were estimated to be $375 (95% confidence interval: $336–$416) for children with ADHD alone and $812 (95% confidence interval: $671–$973) for children with ADHD plus coexisting mental health disorders.
Conclusions.
Children with ADHD use significantly more health care resources and incur significantly higher costs than children without ADHD.
Coexisting mental health disorders substantially increase the cost of treating ADHD.
Resource allocation decisions should consider the contributions of primary care, outpatient mental health, and pharmacy costs to the overall costs of care for children with ADHD.
Related Results
Mitochondrial Dysfunction in Attention Deficit Hyperactivity Disorder
Mitochondrial Dysfunction in Attention Deficit Hyperactivity Disorder
Attention deficit hyperactivity disorder is a neurodevelopmental disorder with primary symptoms of inattention, hyperactivity, and impulsivity, beginning in early childhood. Attent...
Self-Reported Attention Deficit Hyperactivity Disorder Among Students and Factors Affecting It
Self-Reported Attention Deficit Hyperactivity Disorder Among Students and Factors Affecting It
Abstract Objective: To evaluated the prevalence of attention deficit hyperactivity disorder in medical students and its associated factors.Material and Methods: This was a cross-se...
ATTENTION DEFICIT HYPERACTIVITY DISORDER
ATTENTION DEFICIT HYPERACTIVITY DISORDER
Attention deficit hyperactivity disorder (ADHD – attention deficit hyperactivity disorder) and
ADD – attention deficit disorder (ADD) are neurodevelopmental disorders characterized...
Parent Training Interventions for Attention Deficity Hyperactivity Disorder (ADHD) in Children Aged 5 to 18 years
Parent Training Interventions for Attention Deficity Hyperactivity Disorder (ADHD) in Children Aged 5 to 18 years
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder. For a child to be diagnosed with ADHD, adults such as parents, carers, healthcare workers or teach...
Late-onset attention-deficit/hyperactivity disorder as a differential diagnosis of dementia: a case report
Late-onset attention-deficit/hyperactivity disorder as a differential diagnosis of dementia: a case report
Abstract
Background
Although adult attention-deficit/hyperactivity disorder has recently gained increased attention, few reports on attention-deficit/hyperactivity disorder in the ...
Zinc, ferritin, magnesium and copper in a group of Egyptian children with attention deficit hyperactivity disorder
Zinc, ferritin, magnesium and copper in a group of Egyptian children with attention deficit hyperactivity disorder
Abstract
Background
Attention deficit hyperactivity disorder is a behavioral syndrome of childhood characterized by inattention, hyperactivity an...
Prevalence and Associated Factors of Attention-Deficit Hyperactivity Disorder among Children Aged 6-17 Years in North Eastern Ethiopia
Prevalence and Associated Factors of Attention-Deficit Hyperactivity Disorder among Children Aged 6-17 Years in North Eastern Ethiopia
BACKGROUND: Attention-deficit hyperactivity disorder is one of the public neurodevelopmental disorders characterized by impulsivity and restlessness or hyperactivity. This study ai...
Etiologic Classification of Attention-Deficit/Hyperactivity Disorder
Etiologic Classification of Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder is a neurobiological syndrome with an estimated prevalence among children and adolescents of 5%. It is a highly heritable disorder, but acq...

